A new global health alert caused by monkeypox


PDF (Español (España))
Update-PDF (Español (España))
Texto (Español (España))
update (Español (España))


re-emerging infection
Colombia Monkeypox
re-emerging infection

How to Cite

Gomez de la Rosa, R. J., & Rojas Hernandez, J. P. . (2022). A new global health alert caused by monkeypox. Interdisciplinary Journal of Epidemiology and Public Health, 5(2), e–8812. https://doi.org/10.18041/2665-427X/ijeph.2.8812 (Original work published August 14, 2022)


Introduction: Monkeypox is a zoonosis of viral etiology caused by the Monkeypox virus, it is an endemic disease in African countries. Outside this area, the first cases were reported in 2003 in the USA. In May 2022, the World Health Organization (WHO) warned about the increase in the number of cases of monkeypox in non-endemic areas such as countries of Europe and North America, setting off international alarms in the face of the spread of the disease. 

Objective: To review the literature on monkeypox with special emphasis on virological and epidemiological aspects, transmission mechanism, clinical manifestations, and treatment expectations. 

Methods: A review of articles in Spanish and English using terms such as monkeypox, monkeypox, and monkeypox. Using search engines like PubMed, Medline, and ScienceDirect. It was complemented with web pages of recognized institutions because it was necessary to monitor the new cases that are registered worldwide and that are not published due to the speed of appearance and the short period of time. 

Results: The epidemiology, etiology, clinical manifestations, complications, isolation, and treatment possibilities of monkeypox. Conclusions: Monkeypox is an inexact substitute for variola virus smallpox. Early clinical features of the disease and patients not vaccinated against the variola virus are factors associated with poor outcomes. Management strategies and protective measures are key to preventing the spread of the disease.


PDF (Español (España))
Update-PDF (Español (España))
Texto (Español (España))
update (Español (España))


Eskild P, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019; 33:1027-1043. doi: 10.1016/j.idc.2019.03.001

Consejo Ejecutivo, 97. Prevención y lucha contra las enfermedades transmisibles: erradicación de la viruela: destrucción de las reservas de virus variólico. informe del Director General. Organización Mundial de la Salud; 1995. https://apps.who.int/iris/handle/10665/192975

WHO. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication. Geneva: World Health Organization; 1980. https://apps.who.int/iris/handle/10665/39253

Hutin YJ, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001;7(3):434-438. doi: 10.3201/eid0703.017311

Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972; 46(5): 593-597.

E'kitiak M. Management of a suspected case of Monkeypox at Vanga Hospital, Kwilu, Republic Democratic of Congo. Texila Int J Med. 2016; 4(2): 94-102. doi: 10.21522/tijmd.2013.04.02. art009

Reynolds MG, Doty JB, McCollum AM, Olson VA, Nakazawa Y. Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health. Expert Rev Anti Infect Ther. 2019; 17(2): 129-139. doi: 10.1080/14787210.2019.1567330.

von Magnus P, Krag AE, Birkum PK, Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Acta Pathol Microbiol Scand. 1959; 46(2): 156-176. Doi: 10.1111/j.1699-0463.1959.tb00328.x

di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004; 4(1): 15-25. doi: 10.1016/s1473-3099(03)00856-9.

Falendysz EA, Lopera JG, Doty JB, Nakazawa Y, Crill C, Lorenzsonn F,et al. Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.). PLoS Negl Trop Dis. 2017; 11(8): 1-23. doi: 10.1371/journal.pntd.0005809

Pal M, Mengstie F, Kandi V. Epidemiology, diagnosis, and control of monkeypox disease: a comprehensive review. Am J Infect Dis Microbiol. 2017; 5(2): 94-99. doi: 10.12691/ajidm-5-2-4

Breman JG, Kalisa-Ruti, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ. 1980; 58(2): 165-82.

Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004; 350(4): 342-50. doi: 10.1056/NEJMoa032299

PAHO; WHO. Alerta Epidemiológica Viruela símica en países no endémicos. PAHO; 2022. https://reliefweb.int/report/world/alerta-epidemiologica-viruela-simica-en-paises-no-endemicos-20-de-mayo-de-2022

WHO. Multi-country outbreak of monkeypox: situation update. External situation report 2 25 July 2022. WHO; 2022. https://www.who.int/publications/m/item/multi-country-outbreak-of-monkeypox--external-situation-report--2---25-july-2022

WHO Multi-country monkeypox outbreak: situation update: 2022. WHO; 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396

Naciones Unidas. La OMS declara la viruela del mono una emergencia de salud internacional. UN; 2022. https://news.un.org/es/story/2022/07/1512072

World Health Organization. Disease Outbreak News; Multi-country monkeypox outbreak in non-endemic countries. WHO; 2022. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385

El Tiempo. Viruela del mono en Colombia: se identifican nuevos casos. El tiempo; 2022. https://www.eltiempo.com/salud/viruela-del-mono-se-identifican-nuevos-casos-de-viruela-en-el-pais-688746

Reynolds MG, Mccollum AM, Nguete B, Lushima RS, Petersen BW. Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense research. Viruses. 2017; 9: 380; doi:10.3390/v9120380

Oladoye MJ. Monkeypox: A neglected viral zoonotic disease. Europ J Medical Educat Technol. 2021; 14(2): em2108. Doi: 10.30935/ejmets/10911

Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019; 13(10): e0007791. Doi: 10.1371/journal.pntd.0007791

Simpson K, Heymann D, Brown CS, et al. Human monkeypox - After 40 years, an unintended consequence of smallpox eradication. Vaccine. 2020; 38(33): 5077-5081. doi: 10.1016/j.vaccine.2020.04.062

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022; 16(2): e0010141. doi: 10.1371/journal.pntd.0010141

Kabuga AI, El Zowalaty ME. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol. 2019; 91(4): 533-540. doi: 10.1002/jmv.25348.

Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci. 2010; 107(37): 16262-7. doi: 10.1073/pnas.1005769107.

Hoff N, Doshi R, Colwell B, Kebela-Illunga B, Mukadi P, Mossoko M, et al. Evolution of a Disease Surveillance System: An Increase in Reporting of Human Monkeypox Disease in the Democratic Republic of the Congo, 2001-2013. Int J Trop Dis Heal. 2017; 25(2): 1-10. doi:10.9734/ijtdh/2017/35885

Kalthan E, Tenguere J, Ndjapou SG, Koyazengbe TA, Mbomba J, Marada RM, et al. Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic. Med Mal Infect. 2018; 48(4): 263-268. doi: 10.1016/j.medmal.2018.02.010

Vaughan A, Aarons E, Astbury J, Balasegaram S, Beadsworth M, Beck CR, et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Euro surveill. 2018; 23(38): 1800509. doi: 10.2807/1560-7917.ES.2018.23.38.1800509.

CDC. Monkeypox Virus Infection in the United States and Other Non-endemic Countries-2022. CDCHAN-00466. CDC; 2022.

WHO. Faso B African C. Weekly Bull Outbreaks Emergencies. 2020; week 40: 5-11. https://apps.who.int/iris/bitstream/handle/10665/335869/OEW40-280904102020.pdf

Joshua J, Nlerum P. A Neuro-Fussy Based Model for Diagnosis of Monkeypox Diseases A Neuro-Fussy Based Model for Diagnosis of Monkeypox Diseases. Internat J Computer Sci Trends Technol. 2018; 6(2): 143-153.

Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019; 19(8): 872-879. doi: 10.1016/S1473-3099(19)30294-4.

Erez N, Achdout H, Milrot E, Schwartz Y, Wiener-Well Y, Paran N, et al. Diagnosis of Imported Monkeypox, Israel, 2018. Emerging infectious diseases. 2019; 25(5): 980-983. doi: 10.3201/eid2505.190076.

INS. 1 Viruela simica. INS; 2022. https://www.ins.gov.co/Noticias/Paginas/Enfermedades-emergentes.aspx

Ministerio de Salud y Protección Social. Ministra de Salud: "La viruela del mono viene creciendo en Colombia, prevenirla es una responsabilidad" Boletín de Prensa No 427; 2022. https://www.minsalud.gov.co/Paginas/Ministra-de-Salud-La-viruela-del-mono-viene-creciendo-en-Colombia-prevenirla-es-una-responsabilidad.aspx

Ministerio de Salud y Protección Social. Circular Externa 033 Instrucciones para la reducción del impacto frente a la declaración de emergencia de salud pública de importancia internacional (ESPII) por la viruela símica. Ministerio de Salud y Protección Social; 2022. https://www.dssa.gov.co/images/2022/viruela_simica/Circular_No_33_de_2022_Instrucciones_reducion_impacto_frente_declaratoria_emergencia_SP_por_la_viruela_Sim.pdf

Faye O, Pratt CB, Faye M, Fall G, Chitty JA, Diagne MM, Wiley MR, Yinka-Ogunleye AF, et al. Genomic characterisation of human monkeypox virus in Nigeria. Lancet Infect Dis. 2018; 18(3): 246. doi: 10.1016/S1473-3099(18)30043-4.

Rimoin AW, Kisalu N, Kebela-Ilunga B, Mukaba T, Wright LL, Formenty P, et al. Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerging Infect Dis. 2007; 13(6): 934-937. doi: 10.3201/eid1306.061540.

Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, et al. Human monkeypox and smallpox viruses: Genomic comparison. FEBS Lett. 2001; 509(1): 66-70. doi: 10.1016/S0014-5793(01)03144-1

Girirajan S, Campbell C, Eichler E. Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses. Physiol Behav. 2011; 176(5): 139-148. doi: 10.1016/j.chom.2015.02.002.Poxvirus.

Bahar MW, Graham SC, Chen RAJ, et al. How vaccinia virus has evolved to subvert the host immune response. J Struct Biol. 2011; 175(2): 127-134. doi: 10.1016/j.jsb.2011.03.010.

Hendrickson RC, Wang C, Hatcher EL, Lefkowitz EJ. Orthopoxvirus genome evolution: the role of gene loss. Viruses. 2010; 2(9): 1933-1967. doi: 10.3390/v2091933.

Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, et al. A tale of two clades: Monkeypox viruses. J Gen Virol. 2005; 86 (Pt 10): 2661-2672. doi: 10.1099/vir.0.81215-0

Uvarova EA, Totmenin AV, Sandakhchiev LS, Shchelkunov SN. The gene of the complement-binding protein, an important anti-inflammatory factor of orthopoxviruses, is deleted from the genome of Western African strains of monkeypox virus. Dokl Biochem Biophys. 2005; 400(1-6): 14-16. doi:10.1007/s10628-005-0021-y

Chen N, Li G, Liszewski MK, Atkinson JA, Jahrling PB, Feng Z, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology. 2005; 340(1): 46-63. doi: 10.1016/j.virol.2005.05.030

Jezek Z, Grab B, Szczeniowski M V., Paluku KM, Mutombo M. Human monkeypox: secondary attack rates. Bull World Health Organ. 1988; 66(4): 465-470.

Parker S, Nuara A, Buller RML, Schultz DA. Human monkeypox: An emerging zoonotic disease. Future Microbiol. 2007; 2(1): 17-34. doi:10.2217/17460913.2.1.17

Jezek Z, Arita I, Mutombo M, Dunn C, Nakano JH, Szczeniowski M. Four generations of probable person-to-person transmission of human monkeypox. Am J Epidemiol. 1986; 123(6): 1004-1012. doi: 10.1093/oxfordjournals.aje.a114328

Naciones Unidas. La viruela del mono ya está presente en 14 países de América con más de 1300 casos. UN. 2022. https://news.un.org/es/story/2022/07/1511522

Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerg Infect Dis. 2016; 22(6): 1014-1021. doi: 10.3201/eid2206.150579

Morand A, Delaigue S, Morand JJ. Panorama des poxvirus: émergence du monkeypox. Médecine Santé Tropicales. 2017; 27(1): 29-39. doi: 10.1684/mst.2017.0653

Yinka-Ogunleye A, Aruna O, Ogoina D, Aworabhi N, Eteng W, Badaru S, et al. Reemergence of human monkeypox in Nigeria, 2017. Emerg Infect Dis. 2018; 24(6): 1149-1151. doi: 10.3201/eid2406.180017

Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg. 93(2): 2015: 410-415 doi: 10.4269/ajtmh.15-0168

Quiner CA, Moses C, Monroe BP, Nakazawa Y, Doty JB, Hughes CM, et al. Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo. PLoS One. 2017; 12(2): 1-14. doi: 10.1371/journal.pone.0168664.

McCollum AM, Damon IK, Human Monkeypox, Clin Infect Dis. 2014; 58(2): 260-267. doi: 10.1093/cid/cit703

Li D, Wilkins K, Mccollum AM, et al. Evaluation of the GeneXpert for human monkeypox diagnosis. Am J Trop Med Hyg. 2017; 96(2): 405-410 doi:10.4269/ajtmh.16-0567

Mazurkov OY, Kabanov AS, Shishkina LN, Sergeev AA, Skarnovich MO, Bormotov NI, et al. New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol. 2016; 97(5): 1229-1239. doi: 10.1099/jgv.0.000422.

Hoy SM. Tecovirimat: first global approval. Drugs. 2018; 78(13): 1377-1382. doi: 10.1007/s40265-018-0967-6.

Russo AT, Grosenbach DW, Brasel TL, Baker RO, Cawthon AG, Reynolds E, et al. Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques. J Infect Dis. 2018; 218(9): 1490-1499. doi:10.1093/infdis/jiy326

Mucker EM, Goff AJ, Shamblin JD, Grosenbach DW, Damon IK, Mehal J M, et al. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox). Antimicrobial Agents Chemotherapy. 2013; 57(12): 6246-6253. doi: 10.1128/AAC.00977-13

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2022 Interdisciplinary Journal of Epidemiology and Public Health


Download data is not yet available.